Caxton Associates (New York)’s Clorox CLX Stock Holding History

Caxton Associates (New York)’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,359	Closed	-$373K	–	528
2023 Q1	$373K	Buy	+2,359	New	+$354K	0.06%	311
2021 Q4	–	Sell	-2,584	Closed	-$428K	–	568
2021 Q3	$428K	Buy	2,584 +1,466	+131%	+$252K	0.05%	234
2021 Q2	$201K	Sell	1,118 -3,243	-74%	-$592K	0.02%	418
2021 Q1	$841K	Buy	+4,361	New	+$839K	0.08%	87
2020 Q4	–	Sell	-2,594	Closed	-$545K	–	167
2020 Q3	$545K	Buy	+2,594	New	+$578K	0.06%	109
2020 Q2	–	Sell	-6,944	Closed	-$1.2M	–	481
2020 Q1	$1.2M	Buy	+6,944	New	+$1.15M	0.22%	46
2017 Q4	–	Sell	-15,000	Closed	-$1.98M	–	361
2017 Q3	$1.98M	Buy	+15,000	New	+$2.02M	0.07%	198

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caxton Associates (New York)'s CLX Position: Q2 2023 in Review

Caxton Associates (New York) sold out of Clorox (CLX) in Q2 2023, closing a stake of 2,359 shares — an estimated $373K sold.

Caxton Associates (New York) first reported a position in CLX in Q3 2017 and held it in 7 quarters. The position peaked at $1.98M in Q3 2017. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

Caxton Associates (New York) reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
Caxton Associates (New York) sold 2,359 Clorox shares in Q2 2023, an estimated $373K.
Caxton Associates (New York) first reported a position in Clorox in Q3 2017 and held it in 7 quarters.
Caxton Associates (New York)'s Clorox position peaked at $1.98M in Q3 2017.
1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.